Cornerstone
Therapeutics Inc.
1255 Crescent Green Drive, Suite 250
Cary, NC 27518
USA
Manufacturing and Supply Agreement dated 20
August 2007 between Cornerstone Therapeutics Inc.
(“Cornerstone,” formerly known as Critical
Therapeutics, Inc.) and Jagotec AG (“Jagotec”) and (for
the purposes of Clause 20 only) SkyePharma PLC
(“MSA”)
We write in
connection with Clause 9.1 and Schedule 1 of the
MSA.
The parties
have agreed that:-
|
1.
|
|
The
Price for all Product delivered in the Years 2009 (whether before
or after the date of this letter) and 2010 shall be US$[***] per
[***] tablets of Product. As a result of the increase, Jagotec
shall issue to Cornerstone a further invoice for any additional
amounts due fo
|